Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. - Wikidata - awgldk - TriplyDB

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

http://www.wikidata.org/entity/Q33938868

about

Statins research unfinished saga: desirability versus feasibility Are the benefits of statins a class effect?Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database.Development of reusable logic for determination of statin exposure-time from electronic health records.Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study Sex differences in the effectiveness of statins after myocardial infarction.Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.Impact of adherence to statins on coronary artery disease in primary prevention.Treating non-ST-segment elevation ACS. Pros and cons of current strategies.Dyslipidemia in older adults.Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines Evaluation of networks of randomized trials.A systematic review and meta-analysis on the therapeutic equivalence of statins.Clinical implications of pharmacogenetic variation on the effects of statins.Incomparable effectiveness--apples to apples?Would a national pharmaceutical strategy be bad for the cardiovascular health of Canadians?Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice.Reduced risk of poststroke pneumonia in thrombolyzed stroke patients with continued statin treatment.Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures.An evaluation of class effect.How Many “Me-Too” Drugs are Enough? The Case of Physician Preferences for Specific Statins Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

P2860

Q24811267-39757315-E046-480C-9DC5-E89F94F963CD Q33938872-E5C617C9-F005-4F77-B1B7-E957AE13C3CA Q34693650-A1D81363-A69F-4B47-B57E-4C9D6F6D0B78 Q35082814-BD170FFF-23D0-4785-9F69-F0180EA0E025 Q35230210-555385E6-F22D-44EF-9D35-2A6EB2153D88 Q35607051-7EF8DF9E-1C2A-4578-AD7A-5D23FB1523C9 Q36014026-52CBB772-7425-454C-A6A3-CE9B3E3B4793 Q36024456-85E2F78F-73E7-480F-861C-670AE954EAC9 Q36275331-85D59FC5-0E86-4921-B490-1EFEF78953E7 Q36540305-35A9A02C-4DA5-4138-9E13-3DEB59CC2D5A Q36913015-7C6858DD-9DC0-468E-AA7E-D366508D10A9 Q36932658-EF4458D9-A56D-4C15-B326-3FCB256D12E8 Q36966424-65F01597-8423-42DA-8C4F-687D0E57BBEA Q37747986-B8CF1DDC-EC34-48E8-9889-24CF49F8243D Q37818151-9359E8F5-25E1-4D9C-80D8-3E8C9B93DF37 Q42639107-BF4A5BC7-C191-41EA-8E6D-4781B29668DB Q43167477-029B6018-EB31-454A-8C56-AD8271A92B05 Q43271598-087C0388-6C19-4FED-9570-24FB207E7165 Q43725353-C9CE8FAB-A887-4188-81F2-29AB8FD98567 Q44697925-80E63A0B-649D-4A4B-879D-4DC24D1DF91A Q46965255-213C5192-02CD-44C6-8601-754BC96AB57A Q57266853-3ADEA0DF-0298-4FD0-87A6-777DE0B2C62B Q57688960-87C2B2C9-2AF2-4588-BA65-39E58923ABFC

P2860

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

http://www.wikidata.org/entity/Q33938868

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Effectiveness of statins for s ...... an evaluation of class effect.

@ast

Effectiveness of statins for s ...... an evaluation of class effect.

@en

type

label

Effectiveness of statins for s ...... an evaluation of class effect.

@ast

Effectiveness of statins for s ...... an evaluation of class effect.

@en

prefLabel

Effectiveness of statins for s ...... an evaluation of class effect.

@ast

Effectiveness of statins for s ...... an evaluation of class effect.

@en

P1433

Q33938868-3E207AE7-C649-4D40-B7BA-EEED555ED8F1

P1476

Q33938868-990A91A5-B8CB-4B4C-8337-2658A66AC88B

P2093

Q33938868-5598B0C0-CBEC-45F5-B1BF-3FCD84E650F7

Q33938868-AC9CD975-12A3-41D2-895E-E197C203535D

Q33938868-CD34D200-5985-41EE-BC9B-2D82EEF05EBC

Q33938868-FF64927C-B60F-4CB3-9D75-4E530D312403

P2860

Q33938868-07DC5436-EDDB-4359-A5AD-3B5173BA9EAF

Q33938868-0C078EA9-10D9-4DF2-A89F-82AE8A4F18EC

Q33938868-11BE9D0D-A139-46CE-9C4E-A54B34EFF92D

Q33938868-16D52DD8-9B49-46BE-9739-95FEEFD5DA29

Q33938868-18C17850-4AB4-477D-AE3D-E844E645BD70

Q33938868-1B19D1A7-F642-4A6F-BED3-F250DC3EE12B

Q33938868-2088E24A-0B40-4B13-A603-237051C08561

Q33938868-22BD6DFB-36D9-4B01-8A51-FF0E9B6810DF

Q33938868-25F544D1-F9B5-4B9C-AEE5-0303318A20A8

Q33938868-28FFFD62-E066-43FF-930C-2D6DE92E1195

P304

Q33938868-2755845D-6F14-4B95-9689-39D0E4ED1559

P31

Q33938868-416518C2-1670-4BF0-8B2B-7A5C163C143C

P356

Q33938868-E5A9F72D-3BF6-49B9-BC16-412F827F5A90

P407

Q33938868-C5724EF0-DFB8-43E3-8F34-FAC797FB92A3

P433

Q33938868-51E53FBC-7775-46A6-9DB1-E4DC2855731D

P478

Q33938868-AA0AF6C7-0BC7-4A3A-845E-CE02F97C8FFA

P50

Q33938868-66E6D4CF-CA93-412B-B040-A2E903E91CC5

Q33938868-977C1771-4D26-48C1-AD00-A2BE9055DADC

Q33938868-A053A890-B4ED-46B5-A223-D9ABF0AD73F3

Q33938868-E44C2E7F-E3C3-45DF-A13A-9BC4F7EB075F

P577

Q33938868-1B8F1845-CFBE-4A68-8F34-3A25D7508269

P5875

Q33938868-00747D0A-B108-4595-94F4-79959DE86B46

P698

Q33938868-569B8F3D-06C4-49B8-A491-F2E3ADC92E14

P932

Q33938868-252348E2-D933-47E5-B6BE-8FBB60AF0259

P356

P1433

Canadian Medical Association Journal

P1476

Effectiveness of statins for s ...... an evaluation of class effect.

@en

P2093

Elham Rahme

http://www.w3.org/2001/XMLSchema#string

Karin Humphries

http://www.w3.org/2001/XMLSchema#string

Mark J Eisenberg

http://www.w3.org/2001/XMLSchema#string

Zheng Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Did the major clinical trials of statins affect prescribing behaviour?

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?

P304

1187-1194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.1041403

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

Peter C. Austin

Michal Abrahamowicz

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41616001

http://www.w3.org/2001/XMLSchema#string

P698

15851712

http://www.w3.org/2001/XMLSchema#string

P932

557070

http://www.w3.org/2001/XMLSchema#string